FDA Greenlights CAR T Therapy for Large B-Cell Lymphoma – Specialty Pharmacy Times
FDA Greenlights CAR T Therapy for Large B-Cell LymphomaSpecialty Pharmacy TimesOfficials with the FDA have expanded the approval for the chimeric antigen receptor (CAR) T-cell therapy tisagenlecleucel (Kymriah, Novartis) for the treatment of adult pati… Continue reading
